Tetragastrin is a synthetic tetrapeptide corresponding to the C-terminal active site of gastrin. Sequence features include an amidated phenylalanine critical for receptor interaction. Compact structure supports precise conformation in solution. Researchers employ it as a minimal model for gastrin signaling and receptor-binding studies.
CAT No: T32-1
CAS No:1947-37-1
Synonyms/Alias:tetragastrin;Gastrin tetrapeptide;1947-37-1;Cholecystokinin tetrapeptide;Tetragastrin [JAN];CCK-4;Gastrin tetrapeptide amide;cholecystokinin-4;Tetragastrin (JAN);CCRIS 3246;4-7-cholecystokinin-7 (swine);0OL293AV80;Trp-Met-Asp-Phe-NH(2);WMDF-NH(2);TETRAGASTRIN [WHO-DD];UNII-0OL293AV80;CHEMBL120632;(3S)-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;CHEBI:137728;L-Trp-L-Met-L-Asp-L-Phe-NH(2);L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-;L-tryptophyl-L-methionyl-L-aspartylphenyl-Alaninamide;L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide;L-Triptophyl-L-methyionyl-L-alpha-aspartyl-L-phenylalaninamide;L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide;AOC Tetragastrin;AOC Tetrapeptide;AOC-Tetrapeptide;L-PHENYLALANINAMIDE, L-TRYPTOPHYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-;Cholecystokinin 4;L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-;N-((Phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide;(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid;(S)-4-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid;Tetrapeptide, Gastrin;Tetragastrin (hydrochloride);Cholecystokinin-Tetrapeptide;Cholecystokinin (30-33);CKK-4;(3S)-3-(((2S)-2-(((2S)-2-amino-3-(1H-indol-3-yl)propanoyl)amino)-4-methylsulfanylbutanoyl)amino)-4-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid;(3S)-3-((2S)-2-((2S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylsulfanyl)butanamido)-3-(((1S)-1-carbamoyl-2-phenylethyl)carbamoyl)propanoic acid;4, Cholecystokinin;CCK (30-33);Gastrin(14-17)(human);L-Tryptophyl-L-methionyl-L-.alpha.-aspartyl-L-phenylalaninamide;SCHEMBL9710792;CHEBI:32210;DTXSID601027522;BDBM50024317;AKOS040744602;FG108885;H-Trp-Met-Asp-Phe-NH2; H-WMDF-NH2;MS-30582;HY-125556;CS-0092217;D01456;SR-01000883973;SR-01000883973-1;BRD-K70369756-001-01-3;(S)-4-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid;3-{2-[2-Amino-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid;
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More